StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Prices are updated after-hours
Published
Previous years
8
Publishing Date
2023 - 01 - 16
1
2022 - 12 - 14
1
2022 - 09 - 21
1
2022 - 09 - 14
1
2022 - 06 - 09
1
2022 - 02 - 14
1
2021 - 12 - 17
1
2021 - 10 - 07
1
Sector
Health technology
8
Producer manufacturing
1
Tags
Agreement
8
Alzheimer's
10
America
67
Antibody
8
Application
8
Approval
13
Biosimilar
32
Breast
13
Business
9
Cancer
91
Cell
9
Chmp
10
Diabetes
15
Diagnostics
17
Disease
61
Drug
85
Earnings
18
Europe
15
Expansion
10
Expected
35
Eye
15
Fda
22
Financial
24
Global
228
Growing
43
Growth
235
Health
19
Immunotherapy
11
Infection
9
Kisqali
11
Leukemia
10
Liver
11
Market
592
N/a
945
Novartis
132
People
13
Pharma
13
Pharmaceuticals
17
Pipeline
12
Positive
15
Potential
10
Reach
34
Report
194
Research
118
Respiratory
11
Results
38
Risk
10
Sales
9
Sclerosis
13
Set
15
Study
15
T-cell
11
Technology
12
Therapeutics
109
Therapy
64
Treatment
113
Trial
16
Update
10
Vaccine
10
Year
12
Entities
Amgen inc.
1
Bausch health companies inc.
4
Glaxosmithkline plc
1
Idex corporation
1
Iridex corporation
1
Kodiak sciences inc
1
Novartis ag
8
Pfizer, inc.
1
Regeneron pharmaceuticals, inc.
2
Regenxbio inc.
3
Symbols
ABBV
1
ABEO
1
ADVM
2
AKTX
3
ALIM
1
ALPMF
1
ALPMY
1
AMGN
2
AVEO
1
BCRX
1
BDX
1
BHC
8
CGTX
2
CLSD
8
CUBT
1
EYPT
3
FDMT
1
FNCTF
1
GLAXF
1
GSK
1
IEX
1
INCY
3
IRIX
1
ISEE
3
JNJ
3
KOD
7
LCTX
4
LLY
4
MITO
3
MNOV
3
NVS
10
NVSEF
8
OCGN
2
OCS
7
OCUL
3
OPT
4
OTLK
1
PFE
1
REGN
14
RGNX
3
RTGN
2
RZLT
6
SNY
17
SNYNF
15
TEVA
1
TEVJF
3
UBX
5
Exchanges
Nasdaq
8
Nyse
8
Crawled Date
2023 - 01 - 16
1
2022 - 12 - 14
1
2022 - 09 - 21
1
2022 - 09 - 14
1
2022 - 06 - 09
1
2022 - 02 - 14
1
2021 - 12 - 17
1
2021 - 10 - 07
1
Crawled Time
02:00
1
09:00
1
10:00
1
12:00
1
13:00
2
13:15
1
18:00
1
Source
www.biospace.com
1
www.prnewswire.com
7
Sort by:
after hours % change
|
delayed % change
|
gain open
|
gain high
|
gain close
|
publishing date
(GMT-12:00) International Date Line West
(GMT-11:00) American Samoa
(GMT-11:00) Midway Island
(GMT-10:00) Hawaii
(GMT-09:00) Alaska
(GMT-08:00) Pacific Time (US & Canada)
(GMT-08:00) Tijuana
(GMT-07:00) Arizona
(GMT-07:00) Chihuahua
(GMT-07:00) Mazatlan
(GMT-07:00) Mountain Time (US & Canada)
(GMT-06:00) Central America
(GMT-06:00) Central Time (US & Canada)
(GMT-06:00) Guadalajara
(GMT-06:00) Mexico City
(GMT-06:00) Monterrey
(GMT-06:00) Saskatchewan
(GMT-05:00) Bogota
(GMT-05:00) Eastern Time (US & Canada)
(GMT-05:00) Indiana (East)
(GMT-05:00) Lima
(GMT-05:00) Quito
(GMT-04:00) Atlantic Time (Canada)
(GMT-04:00) Caracas
(GMT-04:00) Georgetown
(GMT-04:00) La Paz
(GMT-04:00) Puerto Rico
(GMT-04:00) Santiago
(GMT-03:30) Newfoundland
(GMT-03:00) Brasilia
(GMT-03:00) Buenos Aires
(GMT-03:00) Greenland
(GMT-03:00) Montevideo
(GMT-02:00) Mid-Atlantic
(GMT-01:00) Azores
(GMT-01:00) Cape Verde Is.
(GMT+00:00) Casablanca
(GMT+00:00) Dublin
(GMT+00:00) Edinburgh
(GMT+00:00) Lisbon
(GMT+00:00) London
(GMT+00:00) Monrovia
(GMT+00:00) UTC
(GMT+01:00) Amsterdam
(GMT+01:00) Belgrade
(GMT+01:00) Berlin
(GMT+01:00) Bern
(GMT+01:00) Bratislava
(GMT+01:00) Brussels
(GMT+01:00) Budapest
(GMT+01:00) Copenhagen
(GMT+01:00) Ljubljana
(GMT+01:00) Madrid
(GMT+01:00) Paris
(GMT+01:00) Prague
(GMT+01:00) Rome
(GMT+01:00) Sarajevo
(GMT+01:00) Skopje
(GMT+01:00) Stockholm
(GMT+01:00) Vienna
(GMT+01:00) Warsaw
(GMT+01:00) West Central Africa
(GMT+01:00) Zagreb
(GMT+01:00) Zurich
(GMT+02:00) Athens
(GMT+02:00) Bucharest
(GMT+02:00) Cairo
(GMT+02:00) Harare
(GMT+02:00) Helsinki
(GMT+02:00) Jerusalem
(GMT+02:00) Kaliningrad
(GMT+02:00) Kyiv
(GMT+02:00) Pretoria
(GMT+02:00) Riga
(GMT+02:00) Sofia
(GMT+02:00) Tallinn
(GMT+02:00) Vilnius
(GMT+03:00) Baghdad
(GMT+03:00) Istanbul
(GMT+03:00) Kuwait
(GMT+03:00) Minsk
(GMT+03:00) Moscow
(GMT+03:00) Nairobi
(GMT+03:00) Riyadh
(GMT+03:00) St. Petersburg
(GMT+03:30) Tehran
(GMT+04:00) Abu Dhabi
(GMT+04:00) Baku
(GMT+04:00) Muscat
(GMT+04:00) Samara
(GMT+04:00) Tbilisi
(GMT+04:00) Volgograd
(GMT+04:00) Yerevan
(GMT+04:30) Kabul
(GMT+05:00) Ekaterinburg
(GMT+05:00) Islamabad
(GMT+05:00) Karachi
(GMT+05:00) Tashkent
(GMT+05:30) Chennai
(GMT+05:30) Kolkata
(GMT+05:30) Mumbai
(GMT+05:30) New Delhi
(GMT+05:30) Sri Jayawardenepura
(GMT+05:45) Kathmandu
(GMT+06:00) Almaty
(GMT+06:00) Astana
(GMT+06:00) Dhaka
(GMT+06:00) Urumqi
(GMT+06:30) Rangoon
(GMT+07:00) Bangkok
(GMT+07:00) Hanoi
(GMT+07:00) Jakarta
(GMT+07:00) Krasnoyarsk
(GMT+07:00) Novosibirsk
(GMT+08:00) Beijing
(GMT+08:00) Chongqing
(GMT+08:00) Hong Kong
(GMT+08:00) Irkutsk
(GMT+08:00) Kuala Lumpur
(GMT+08:00) Perth
(GMT+08:00) Singapore
(GMT+08:00) Taipei
(GMT+08:00) Ulaanbaatar
(GMT+09:00) Osaka
(GMT+09:00) Sapporo
(GMT+09:00) Seoul
(GMT+09:00) Tokyo
(GMT+09:00) Yakutsk
(GMT+09:30) Adelaide
(GMT+09:30) Darwin
(GMT+10:00) Brisbane
(GMT+10:00) Canberra
(GMT+10:00) Guam
(GMT+10:00) Hobart
(GMT+10:00) Melbourne
(GMT+10:00) Port Moresby
(GMT+10:00) Sydney
(GMT+10:00) Vladivostok
(GMT+11:00) Magadan
(GMT+11:00) New Caledonia
(GMT+11:00) Solomon Is.
(GMT+11:00) Srednekolymsk
(GMT+12:00) Auckland
(GMT+12:00) Fiji
(GMT+12:00) Kamchatka
(GMT+12:00) Marshall Is.
(GMT+12:00) Wellington
(GMT+12:45) Chatham Is.
(GMT+13:00) Nuku'alofa
(GMT+13:00) Samoa
(GMT+13:00) Tokelau Is.
tags :
Macular
symbols :
NVSEF
save search
Diabetic Macular Edema Treatment Global Market Report 2022: Prevalence of Diabetes Worldwide Bolsters Sector
Published:
2023-01-16
(Crawled : 12:00)
- prnewswire.com
IEX
|
$227.04
0.42%
0.0%
240K
|
Producer Manufacturing
|
Email alert
Add to watchlist
REGN
|
$896.27
0.26%
0.25%
500K
|
Health Technology
|
Email alert
Add to watchlist
NVS
|
$94.36
1.93%
0.0%
2.3M
|
Health Technology
|
Email alert
Add to watchlist
IRIX
|
$2.95
-2.32%
-2.37%
50K
|
Health Technology
|
Email alert
Add to watchlist
NVSEF
|
$93.6375
6.88%
82K
|
Health Technology
|
Email alert
Add to watchlist
treatment
global
report
macular
diabetes
market
diabetic
Outlook on the Age-related Macular Degeneration Global Market to 2030 - Players Include Bayer, Pfizer, Bausch Health and Amgen Among Others
Published:
2022-12-14
(Crawled : 13:00)
- prnewswire.com
NVSEF
|
$93.6375
6.88%
82K
|
Health Technology
|
23.48%
|
O:
1.74%
H:
0.45%
C:
-1.8%
NVS
|
$94.36
1.93%
0.0%
2.3M
|
Health Technology
|
3.45%
|
O:
1.0%
H:
1.29%
C:
0.45%
BHC
|
$8.69
1.05%
0.0%
2.9M
|
Health Technology
|
12.71%
|
O:
-0.39%
H:
3.26%
C:
2.34%
AMGN
|
$269.03
2.39%
2.33%
3.4M
|
Health Technology
|
-1.22%
|
O:
-0.11%
H:
0.51%
C:
-0.31%
global
macular
health
market
Macular Degeneration Treatment Market to Surpass US$ 21.1 Bn by 2031: TMR Study
Published:
2022-09-21
(Crawled : 02:00)
- prnewswire.com
NVSEF
|
$93.6375
6.88%
82K
|
Health Technology
|
44.73%
|
O:
0.98%
H:
0.0%
C:
-1.99%
PFE
A
|
$26.0
2.4%
-0.15%
38M
|
Health Technology
|
-41.93%
|
O:
0.09%
H:
0.38%
C:
-1.99%
NVS
|
$94.36
1.93%
0.0%
2.3M
|
Health Technology
|
18.57%
|
O:
-0.73%
H:
0.04%
C:
-1.85%
REGN
|
$896.27
0.26%
0.25%
500K
|
Health Technology
|
27.35%
|
O:
-0.47%
H:
1.24%
C:
-2.32%
treatment
macular
study
market
Macular Degeneration Treatment Global Market to Reach $10.65 Billion by 2026 at a CAGR of 7.15%
Published:
2022-09-14
(Crawled : 10:00)
- prnewswire.com
GLAXF
|
News
|
$20.2
-14.18%
510
|
Health Technology
|
31.38%
|
O:
-4.98%
H:
7.63%
C:
2.67%
NVS
|
$94.36
1.93%
0.0%
2.3M
|
Health Technology
|
15.14%
|
O:
-0.55%
H:
0.42%
C:
-0.72%
GSK
|
News
|
$39.75
1.22%
0.0%
1.6M
|
Health Technology
|
25.67%
|
O:
-0.6%
H:
0.41%
C:
-0.76%
BHC
|
$8.69
1.05%
0.0%
2.9M
|
Health Technology
|
18.07%
|
O:
0.41%
H:
11.64%
C:
6.22%
RGNX
|
$15.67
-2.73%
-2.87%
570K
|
Health Technology
|
-40.41%
|
O:
0.38%
H:
2.53%
C:
1.48%
treatment
global
macular
market
Global Macular Degeneration Treatment Market Report (2022 to 2027) - Industry Trends, Share, Size, Growth, Opportunity and Forecasts
Published:
2022-06-09
(Crawled : 18:00)
- prnewswire.com
NVSEF
|
$93.6375
6.88%
82K
|
Health Technology
|
27.11%
|
O:
-1.02%
H:
0.0%
C:
0.0%
NVS
|
$94.36
1.93%
0.0%
2.3M
|
Health Technology
|
8.03%
|
O:
0.49%
H:
0.47%
C:
-1.59%
BHC
|
$8.69
1.05%
0.0%
2.9M
|
Health Technology
|
-3.44%
|
O:
-0.89%
H:
0.67%
C:
-6.05%
RGNX
|
$15.67
-2.73%
-2.87%
570K
|
Health Technology
|
-30.76%
|
O:
-0.75%
H:
0.53%
C:
-3.07%
treatment
report
macular
market
Macular Degeneration Treatment Market size worth $ 11.98 Billion, Globally, by 2028 at 6.01% CAGR: Verified Market Research®
Published:
2022-02-14
(Crawled : 09:00)
- prnewswire.com
NVS
|
$94.36
1.93%
0.0%
2.3M
|
Health Technology
|
10.27%
|
O:
0.96%
H:
0.0%
C:
-0.81%
BHC
|
$8.69
1.05%
0.0%
2.9M
|
Health Technology
|
-65.42%
|
O:
-0.48%
H:
1.52%
C:
-1.08%
RGNX
|
$15.67
-2.73%
-2.87%
570K
|
Health Technology
|
-37.49%
|
O:
0.92%
H:
0.87%
C:
-0.91%
research
treatment
macular
Beovu (brolucizumab injection) now publicly reimbursed in Ontario and New Brunswick for the treatment of neovascular (wet) age-related macular degeneration
Published:
2021-12-17
(Crawled : 13:00)
- biospace.com/
NVSEF
|
$93.6375
6.88%
82K
|
Health Technology
|
9.65%
|
O:
0.52%
H:
0.0%
C:
0.0%
NVS
|
$94.36
1.93%
0.0%
2.3M
|
Health Technology
|
10.3%
|
O:
0.96%
H:
0.0%
C:
0.0%
treatment
injection
macular
Diabetic Macular Edema Market size worth $ 4.87 Billion, Globally, by 2028 at 2.86% CAGR: Verified Market Research®
Published:
2021-10-07
(Crawled : 13:15)
- prnewswire.com
NVSEF
|
$93.6375
6.88%
82K
|
Health Technology
|
15.09%
|
O:
2.72%
H:
0.1%
C:
0.1%
NVS
|
$94.36
1.93%
0.0%
2.3M
|
Health Technology
|
15.37%
|
O:
0.62%
H:
1.0%
C:
0.22%
KOD
|
$3.36
-3.17%
-3.27%
600K
|
Health Technology
|
-96.68%
|
O:
0.34%
H:
4.38%
C:
2.23%
research
macular
diabetic
diabetes
Gainers vs Losers
67%
33%
Top 10 Gainers
Your saved searches
Save your searches and get alerts when important news are released.